Page last updated: 2024-10-29

nsc 664704 and Allergic Encephalomyelitis

nsc 664704 has been researched along with Allergic Encephalomyelitis in 1 studies

kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).

Research Excerpts

ExcerptRelevanceReference
"Kenpaullone and Roscovitine suppressed experimental autoimmune encephalomyelitis (EAE), a typical Th17-mediated autoimmune disease model."1.39CDK inhibitors suppress Th17 and promote iTreg differentiation, and ameliorate experimental autoimmune encephalomyelitis in mice. ( Asakawa, M; Ito, M; Kimura, A; Kondo, T; Kotani, H; Nagai, S; Tani, I; Tsuruta, S; Wei, X; Yoshida, H; Yoshimura, A, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshida, H1
Kotani, H1
Kondo, T1
Tani, I1
Wei, X1
Tsuruta, S1
Kimura, A1
Asakawa, M1
Ito, M1
Nagai, S1
Yoshimura, A1

Other Studies

1 other study available for nsc 664704 and Allergic Encephalomyelitis

ArticleYear
CDK inhibitors suppress Th17 and promote iTreg differentiation, and ameliorate experimental autoimmune encephalomyelitis in mice.
    Biochemical and biophysical research communications, 2013, Jun-07, Volume: 435, Issue:3

    Topics: Animals; Benzazepines; Cell Differentiation; Cyclin-Dependent Kinases; Encephalomyelitis, Autoimmune

2013